Pharmacotherapy for Human Immunodeficiency Virus-Associated Nephropathy.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1761, doi. 10.1592/phco.2005.25.12.1761
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2005 AND VI 25 AND IP 12
Results: 16
1
2
Inhalation Anesthesiology and Volatile Liquid Anesthetics: Focus on Isoflurane, Desflurane, and Sevoflurane.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1173, doi. 10.1592/phco.2005.25.12.1773
- By:
- Publication type:
- Article
3
Use of Ankle Brachial Index Screening for Selecting Patients for Antiplatelet Drug Therapy.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1826, doi. 10.1592/phco.2005.25.12.1826
- By:
- Publication type:
- Article
4
Tumor Lysis Syndrome After Bortezomib Therapy for Plasma Cell Leukemia.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1820, doi. 10.1592/phco.2005.25.12.1820
- By:
- Publication type:
- Article
5
Asthma-Related Health Care Resource Use Among Patients Starting Fluticasone or Montelukast Therapy.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1752, doi. 10.1592/phco.2005.25.12.1752
- By:
- Publication type:
- Article
6
Gabapentin-Induced Neurologic Toxicities.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1817, doi. 10.1592/phco.2005.25.12.1817
- By:
- Publication type:
- Article
7
Low-Dose Vitamin K to Augment Anticoagulation Control.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1746, doi. 10.1592/phco.2005.25.12.1746
- By:
- Publication type:
- Article
8
Effectiveness of Pharmacist-Administered Diabetes Mellitus Education and Management Services.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1809, doi. 10.1592/phco.2005.25.12.1809
- By:
- Publication type:
- Article
9
Predictors of Noncompliance with Warfarin Therapy in an Outpatient Anticoagulation Clinic.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1801, doi. 10.1592/phco.2005.25.12.1801
- By:
- Publication type:
- Article
10
An Approach to Evaluating Drug-Nutrient Interactions.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1789, doi. 10.1592/phco.2005.25.12.1789
- By:
- Publication type:
- Article
11
Absence of Electrocardiographic Findings and Improved Function with Once-Daily Tiotropium in Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1708, doi. 10.1592/phco.2005.25.12.1708
- By:
- Publication type:
- Article
12
Evaluation of Diagnostic Tests and Argatroban or Lepirudin Therapy in Patients with Suspected Heparin-Induced Thrombocytopenia.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1736, doi. 10.1592/phco.2005.25.12.1736
- By:
- Publication type:
- Article
13
Decreased Persistence to Cholinesterase Inhibitor Therapy with Concomitant Use of Drugs That Can Impair Cognition.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1729, doi. 10.1592/phco.2005.25.12.1729
- By:
- Publication type:
- Article
14
Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease: An Overview.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1687, doi. 10.1592/phco.2005.25.12.1687
- By:
- Publication type:
- Article
15
Effect of High-Dose Vitamin C on Hepatic Cytochrome P450 3A4 Activity.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1725, doi. 10.1592/phco.2005.25.12.1725
- By:
- Publication type:
- Article
16
Absence of QTc-Interval-Prolonging or Hemodynamic Effects of a Single Dose of Bitter-Orange Extract in Healthy Subjects.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 12, p. 1719, doi. 10.1592/phco.2005.25.12.1719
- By:
- Publication type:
- Article